When coagulation characteristics were assessed, activated thromboplastin as well as prothrombin time at sepsis onset did not differ significantly whereas the prothrombin time on ICU discharge was significantly lower in unmatched patients with discontinued treatment (p = 0.02). This evidence concerns the gene F3 and Sepsis.